These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Place of chemotherapy in the treatment of invasive bladder tumors].
    Author: Pariente JL, Theodore C, Davin JL, Rischmann P, Chopin D.
    Journal: Prog Urol; 1999 Apr; 9(2):219-24. PubMed ID: 10370944.
    Abstract:
    Urothelial bladder tumours are chemosensitive. Chemotherapy is indicated in the case of metastatic bladder cancer. The M-VAC protocol remains the reference treatment. The efficacy of this protocol is estimated to be about 18% in terms of complete responses and 20% of these responding patients achieve long-term survival. New combinations, comprising drugs such as ifosfamide, gallium nitrate, paclitaxel or gemcitabine, appear to be promising. Neoadjuvant and adjuvant chemotherapy cannot be considered to be standard treatment at the present time.
    [Abstract] [Full Text] [Related] [New Search]